Related references
Note: Only part of the references are listed.Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis
Suman Gupta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects
Stephen Patterson et al.
TRENDS IN PARASITOLOGY (2014)
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
Andrea Trochine et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Assessing the Essentiality of Leishmania donovani Nitroreductase and Its Role in Nitro Drug Activation
Susan Wyllie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation
Belinda S. Hall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Benznidazole-Resistance in Trypanosoma cruzi Is a Readily Acquired Trait That Can Arise Independently in a Single Population
Ana Maria Mejia et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
High-throughput decoding of antitrypanosomal drug efficacy and resistance
Sam Alsford et al.
NATURE (2012)
The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis
Susan Wyllie et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites
Belinda S. Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Trypanosoma brucei Mitochondrial Respiratome: Composition and Organization in Procyclic Form
Nathalie Acestor et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
Cross-Resistance to Nitro Drugs and Implications for Treatment of Human African Trypanosomiasis
Antoaneta Y. Sokolova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis
Deuan C. Jones et al.
BIOCHEMICAL PHARMACOLOGY (2010)
A Molecular Mechanism for Eflornithine Resistance in African Trypanosomes
Isabel M. Vincent et al.
PLOS PATHOGENS (2010)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
A comparative study of methylglyoxal metabolism in trypanosomatids
Neil Greig et al.
FEBS JOURNAL (2009)
Four histone variants mark the boundaries of polycistronic transcription units in Trypanosoma brucei
T. Nicolai Siegel et al.
GENES & DEVELOPMENT (2009)
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Gerardo Priotto et al.
LANCET (2009)
Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G plus C)-biased genomes
Iwanka Kozarewa et al.
NATURE METHODS (2009)
A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes
Shane R. Wilkinson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Hemizygous subtelomeres of an African trypanosome chromosome may account for over 75% of chromosome length
Sergio Callejas et al.
GENOME RESEARCH (2006)
Drug resistance in leishmaniasis
SL Croft et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
The myo-inositol-1-phosphate synthase gene is essential in Tryponosoma brucei
KL Martin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2005)
The genome of the African trypanosome Trypanosoma brucei
M Berriman et al.
SCIENCE (2005)
Functional mapping of a trypanosome centromere by chromosome fragmentation identifies a 16-kb GC-rich transcriptional strand-switch' domain as a major feature
SO Obado et al.
GENOME RESEARCH (2005)
Share Paper
